Covered recipient · General Payments record
DAISY BANG
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$1,261.91
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $642.56 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $216.14 | 13 |
| Janssen Biotech, Inc. | $147.31 | 4 |
| Lilly USA, LLC | $50.47 | 2 |
| UCB, Inc. | $49.74 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $43.16 | 2 |
| Mallinckrodt Hospital Products Inc. | $42.26 | 2 |
| GlaxoSmithKline, LLC. | $31.53 | 1 |
| Sandoz Inc. | $23.62 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.68 | 1 |
| Amgen Inc. | $18.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.48 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274797 | CMS |
| ABBVIE INC. | $8.07 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274799 | CMS |
| ABBVIE INC. | $19.70 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274801 | CMS |
| ABBVIE INC. | $17.86 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274803 | CMS |
| ABBVIE INC. | $17.77 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274805 | CMS |
| ABBVIE INC. | $8.16 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274807 | CMS |
| ABBVIE INC. | $14.50 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274809 | CMS |
| ABBVIE INC. | $27.55 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274811 | CMS |
| ABBVIE INC. | $16.05 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274813 | CMS |
| ABBVIE INC. | $20.34 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274815 | CMS |
| ABBVIE INC. | $22.04 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274817 | CMS |
| ABBVIE INC. | $26.86 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274819 | CMS |
| ABBVIE INC. | $2.76 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103274821 | CMS |
| Amgen Inc. | $18.65 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117197159 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.68 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101246836 | CMS |
| GlaxoSmithKline, LLC. | $31.53 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115983762 | CMS |
| Janssen Biotech, Inc. | $36.04 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078384728 | CMS |
| Janssen Biotech, Inc. | $41.36 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078384738 | CMS |
| Janssen Biotech, Inc. | $34.69 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078384842 | CMS |
| Janssen Biotech, Inc. | $35.22 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078384752 | CMS |
| Lilly USA, LLC | $21.83 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136137162 | CMS |
| Lilly USA, LLC | $28.64 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136127435 | CMS |
| Mallinckrodt Hospital Products Inc. | $21.11 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145048709 | CMS |
| Mallinckrodt Hospital Products Inc. | $21.15 | 12/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145048711 | CMS |
| Novartis Pharmaceuticals Corporation | $20.55 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086777821 | CMS |
| Novartis Pharmaceuticals Corporation | $22.61 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086777823 | CMS |
| Sandoz Inc. | $23.62 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089363635 | CMS |
| UCB, Inc. | $23.15 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143459725 | CMS |
| UCB, Inc. | $26.59 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143459729 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.